InsituGen
InsituGen Limited is a New Zealand biotech that sells cell-free bioassay test kits — firstFlagX for anti-doping laboratories and NeuterReady for companion animal maturity assessment — plus contract testing services, targeting anti-doping labs, veterinary clinics, and supplement manufacturers.
- Company typePrivate
- Founded2020
- HeadquartersDunedin, New Zealand
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What InsituGen does
InsituGen Limited is a New Zealand-based biotechnology company founded in 2020 that has commercialized a proprietary, multi-patented cell-free bioassay platform for the non-targeted detection of steroid hormone (androgen and estrogen) bioactivity. The platform replicates natural biological signaling pathways of estrogen and androgen receptors in a cell-free format, eliminating the requirement for live cell culture and enabling detection of novel and designer steroid compounds that targeted mass spectrometry methods can miss. Results are delivered in approximately two hours using standard laboratory fluorometers.
The company's commercial product portfolio comprises firstFlagX (FFX-1), a 96-well androgen bioactivity test kit marketed to equine anti-doping laboratories for screening samples from thoroughbred racehorses, racing camels, and human athletes; NeuterReady, a veterinary kit and service for assessing biological maturity to inform spay/neuter timing in companion animals; and a fee-for-service laboratory testing offering operated from the company's Dunedin, New Zealand facility. Named enterprise customers include Plasmaide (sports supplements), Biogold (pine pollen extracts), and Organic Initiative (organic feminine care), demonstrating traction in the supplement and natural-product testing segment.
InsituGen monetizes through one-time test kit sales and transaction-based laboratory testing services, with pricing set on a quote basis by volume and customer type. Go-to-market combines an exclusive worldwide distribution partnership with Berlinger Special AG (channel coverage into 175+ countries for firstFlagX in the equine anti-doping segment) with direct enterprise sales for NeuterReady and contract testing. The company is privately held, has between 11 and 50 employees, has raised approximately US$2.5 million in disclosed external capital since 2020 across NZ, US, and European investors, and is actively raising additional capital to support product development and commercial expansion.
InsituGen firmographics
Firmographics- Name
- InsituGen
- Legal name
- InsituGen Limited
- Website
- https://insitugen.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InsituGen Limited is a New Zealand biotech that sells cell-free bioassay test kits — firstFlagX for anti-doping laboratories and NeuterReady for companion animal maturity assessment — plus contract testing services, targeting anti-doping labs, veterinary clinics, and supplement manufacturers.
- Ownership category
- akta.pro rank
InsituGen industry classification
Industry- Product category
- Bioassay Diagnostic Test Kits
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH)
- akta.pro secondary industries
- Reproductive & Endocrinology Diagnostics (Fertility, Hormones) (HLAMADAF), Analytical Testing & QC Release Services (potency, purity, sterility) (HLAAAKAG)
Keywords
Where InsituGen is headquartered
LocationHeadquarters
- HQ city
- Dunedin
- HQ country
- New Zealand
- HQ region
- Oceania
Offices2 records
Markets served
InsituGen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Test Kit Product Sales: Sale of proprietary test kits including firstFlagX and NeuterReady to laboratories, veterinary clinics, and anti-doping facilities. Revenue generated from initial kit purchases with recurring demand from ongoing testing requirements.
- Laboratory Testing Services: Contract testing services offered through InsituGen's New Zealand laboratory facility for samples requiring specialized bioactivity analysis. Provides fee-for-service revenue for complex or high-volume testing needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Enterprise/B2B pricing for laboratory test kits |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
InsituGen product offering
Product offeringCore offering
InsituGen develops and sells proprietary cell-free bioassay test kits for detecting androgen and estrogen steroid hormone bioactivity. The company offers the firstFlagX androgen bioactivity test kit for anti-doping laboratories, the NeuterReady veterinary test kit for companion animal hormone assessment, and contract testing services performed at its Dunedin, New Zealand laboratory.
Product overview
InsituGen offers a portfolio of bioassay-based products and services for steroid hormone detection. The core offering centers on cell-free bioassay technology that replicates natural biological signaling pathways of estrogen and androgen receptors. The main products are firstFlagX (an androgen bioactivity test kit for use in reference laboratories), NeuterReady (a veterinary testing service for companion animal maturity assessment), and a laboratory testing service for external customers. firstFlagX and NeuterReady are the two commercial products launched since the company's founding in 2020, with testing services providing additional customer access to the technology.
Differentiator
Problem solved
Functional benefit
Brands
- firstFlagX: InsituGen's bioassay technology transformed into a ready-to-use kit for the detection of total androgen bioactivity. Used in thoroughbred horse and camel anti-doping laboratories.
- NeuterReady
Products and services
- firstFlagX Androgen Bioactivity Test Kit (FFX-1) A ready-to-use 96-well format bioassay kit that detects total androgen bioactivity, including unknown androgens, designer steroids, testosterone-mimics, and any compound that binds to the androgen receptor. Delivers results within 2 hours using standard laboratory fluorometers. Used by reference and anti-doping laboratories.
- NeuterReady Veterinary testing service and kit for determining optimal timing for neutering/spaying companion animals based on biological maturity assessment through circulating androgen bioactivity, enabling data-driven treatment decisions. Used by veterinary clinics and companion animal owners.
- Testing Services – Test with Us Non-targeted testing service using InsituGen's cell-free bioassay technology at the New Zealand laboratory, testing human supplements, products, clinical plasma samples, and environmental samples for estrogen and androgen bioactivity.
Quantifiable outcome
- Results delivered in 2 hours compared to 24-48 hours for traditional cell-based methods
- +2 more outcomes
Companies that use InsituGen
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
InsituGen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
InsituGen partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Berlinger Special AGcoreExclusive worldwide distribution partnership for firstFlagX androgen bioactivity test kits to equine anti-doping laboratories. Berlinger Special AG, a specialized provider of anti-doping equipment and services, distributes InsituGen's firstFlagX test kits globally, enabling market access to laboratories in over 175 countries. The partnership leverages Berlinger's established relationships with racing federations and anti-doping authorities.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
InsituGen competitors and assessment
Company assessmentBroad incumbents
- Agilent Technologies: Major analytical instrument provider (mass spec, chromatography) widely used in anti-doping reference laboratories. Represents the incumbent targeted-detection paradigm that InsituGen's non-targeted bioassay seeks to complement.
- IDEXX Laboratories: Leading veterinary diagnostics company serving companion animal clinics with in-clinic and reference lab testing. Comparable as a scaled veterinary diagnostics platform into which NeuterReady's hormone maturity test could be distributed.
- SGS: Global testing, inspection, and certification company with dedicated supplement, food, and environmental contaminant testing services. Comparable as an established contract testing alternative for supplement and environmental bioactivity work.
- Thermo Fisher Scientific: Global analytical instruments and life sciences leader offering mass spectrometers, immunoassays, and clinical diagnostics that compete with and complement InsituGen's bioassay in anti-doping and clinical endocrinology reference labs.
- Waters Corporation: Analytical instrument vendor (LC-MS/MS) used in equine and human anti-doping laboratories worldwide. Represents an alternative screening technology stack competing for the same lab budget.
- Eurofins Scientific: Global testing services conglomerate with extensive anti-doping, supplement, and environmental testing capacity. Comparable as a large-scale service-lab competitor and potential channel partner for InsituGen's test kits.
- Zoetis: Largest global animal health company with diagnostics and reproductive management products. Closely comparable as the dominant channel and R&D investor in companion animal diagnostics where NeuterReady competes.
- SCIEX (Danaher): Mass spectrometry platform vendor with deep penetration in anti-doping and clinical endocrinology reference labs. Competes for the same analytical workflow budget that InsituGen's firstFlagX targets.
Direct peers
- Berlinger Special AG: Swiss anti-doping equipment specialist and exclusive worldwide distributor of InsituGen's firstFlagX kits. Operates in the same equine/human anti-doping laboratory customer segment and supplies complementary sample collection and cold-chain equipment used alongside bioassay testing.
- Randox Laboratories: Clinical and anti-doping diagnostics company offering biochip immunoassays and evidence-testing kits to sports, forensic, and clinical labs. Comparable as a multi-kit specialty diagnostics provider in anti-doping reference laboratories.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
InsituGen social profiles
Digital presenceInsituGen financial estimates
Financial estimateRevenue estimate
Valuation estimate
InsituGen leadership team
Management profileNumber of profiles
Profiles10 records
InsituGen funding detail
Funding detailFunding overview
Funding rounds5 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InsituGen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InsituGen
What does InsituGen do?
InsituGen develops and sells proprietary cell-free bioassay test kits for detecting androgen and estrogen steroid hormone bioactivity. The company offers the firstFlagX androgen bioactivity test kit for anti-doping laboratories, the NeuterReady veterinary test kit for companion animal hormone assessment, and contract testing services performed at its Dunedin, New Zealand laboratory.
Is InsituGen a public or private company?
InsituGen is a private company. It is classified as venture growth investor backed and is currently operating.
When was InsituGen founded?
InsituGen was founded in 2020. It employs 11 to 50 people.
Where is InsituGen based?
InsituGen is headquartered in Dunedin, New Zealand, in the Oceania region.
How does InsituGen make money?
Two revenue lines are on record. Test Kit Product Sales are the primary driver. The others are laboratory Testing Services.
Who are InsituGen's main competitors?
Broad incumbents on record are Agilent Technologies, IDEXX Laboratories, SGS, Thermo Fisher Scientific, Waters Corporation, Eurofins Scientific, Zoetis and SCIEX (Danaher). Direct peers are Berlinger Special AG and Randox Laboratories.
Does InsituGen have an API?
No public API is recorded for InsituGen.
What industry is InsituGen in?
InsituGen's product category is Bioassay Diagnostic Test Kits. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAMADAF, Reproductive & Endocrinology Diagnostics (Fertility, Hormones). Its NAICS code is 325413 and its SIC code is 2835.